Elyxium Wealth’s Kura Oncology KURA Stock Holding History

Elyxium Wealth’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.47K	Buy	+511	New	+$5.72K	﹤0.01%	1152

Other funds holding KURA

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Xcel Wealth Management Holly Hill, Florida $404M AUM 16.8% 1-Year Est. Return

Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return

Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return

Pavaki Capital Management Pueblo, Colorado $294M AUM 34.46% 1-Year Est. Return

Flower City Capital Pittsford, New York $234M AUM 15.69% 1-Year Est. Return

Elyxium Wealth's KURA Position: Q3 2026 in Review

Elyxium Wealth opened a new position in Kura Oncology (KURA) in Q3 2026: 511 shares worth $5.47K. The stake represents ﹤0.01% of the portfolio and ranks #1152 among its holdings.

41 funds tracked by Wall St. Rank hold KURA as of Q3 2026.

Elyxium Wealth held 511 shares of Kura Oncology worth $5.47K as of Q3 2026.
Kura Oncology was a new Elyxium Wealth position in Q3 2026.
Kura Oncology made up ﹤0.01% of Elyxium Wealth's portfolio in Q3 2026, its #1152 holding.
41 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.

Based on Elyxium Wealth's 13F filing for Q3 2026, filed 27 Oct 2026.